(Q37777632)

23 August 2017

0 references

1 reference

title

Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer (English)

1 reference

23 August 2017

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer (English)

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

16 June 2024

1 reference

5

Eric Pujade-Lauraine

0 references

Amit M Oza

3

object named as

Amit M. Oza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20683400

16 June 2024

author name string

Alexander Reuss

4

1 reference

23 August 2017

Nadeem Siddiqui

7

1 reference

23 August 2017

Nicoletta Colombo

8

1 reference

23 August 2017

Jacobus Pfisterer

10

1 reference

23 August 2017

Andreas du Bois

11

1 reference

23 August 2017

Gynecologic Cancer InterGroup

12

1 reference

23 August 2017

Helen J. Mackay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20683400

16 June 2024

Mark F. Brady

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20683400

16 June 2024

Ann M. Swart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20683400

16 June 2024

Michael A. Bookman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20683400

16 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20683400

16 June 2024

publication date

1 August 2010

1 reference

full work available at URL

23 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2FIGC.0b013e3181dd0110

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

https://syndication.highwire.org/content/doi/10.1111/IGC.0b013e3181dd0110

16 June 2024

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

International Journal of Gynecological Cancer

16 June 2024

published in

1 reference

23 August 2017

volume

20

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

945-952

1 reference

23 August 2017

1

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

16 June 2024

2

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

16 June 2024

3

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Mucinous tumors of the ovary. A clinicopathologic study of 70 cases

16 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel

16 June 2024

5

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

16 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Secondary surgical cytoreduction for advanced ovarian carcinoma

16 June 2024

7

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

16 June 2024

8

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.

16 June 2024

9

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S

16 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

16 June 2024

11

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

16 June 2024

13

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.

16 June 2024

14

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.

16 June 2024

16

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Acta Obstetrica et Gynaecologica Japonica

16 June 2024

17

44

827

Sugawa

1992

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Interobserver variability in the interpretation of epithelial ovarian cancer

16 June 2024

18

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

16 June 2024

19

1 reference

https://api.crossref.org/works/10.1111/IGC.0B013E3181DD0110

16 June 2024

Identifiers

1 reference

23 August 2017

1 reference